Arcellx (ACLX) Capital Expenditures (2021 - 2025)
Arcellx (ACLX) recorded quarterly Capital Expenditures of $1.8 million in Q4 2025, up 338.02% quarter-over-quarter from -$768000.0 in Q3 2025, and down 84.89% on a YoY basis from $12.1 million in Q4 2024.
Arcellx (ACLX) Capital Expenditures (2021 - 2025) Analysis & Trends
Arcellx's Capital Expenditures history runs 5 years deep, the most recent figure standing at $1.8 million for Q4 2025.
- In Q4 2025, Capital Expenditures fell 84.89% year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $2.3 million (down 82.68% YoY), while the FY2025 annual figure was $2.3 million, down 82.68% from the prior year.
- Capital Expenditures was $1.8 million for Q4 2025 at Arcellx, up from -$768000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $14.2 million in Q4 2023 to a low of -$8.3 million in Q3 2024.
- Historically, Capital Expenditures has averaged $2.2 million across 5 years, with a median of $633500.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures soared 4082.94% in 2023, then sank 729.44% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $4.9 million in 2021, then sank by 93.11% to $340000.0 in 2022, then jumped by 4082.94% to $14.2 million in 2023, then fell by 14.92% to $12.1 million in 2024, then sank by 84.89% to $1.8 million in 2025.
- The last three Capital Expenditures figures came in at $1.8 million (Q4 2025), -$768000.0 (Q3 2025), and $487000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.83 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | -768,000.00 |
| Sep 30, 2025 | -768,000.00 |
| Jun 30, 2025 | 487,000.00 |
| Jun 30, 2025 | 487,000.00 |
| Mar 31, 2025 | 780,000.00 |
| Mar 31, 2025 | 780,000.00 |
| Dec 31, 2024 | 12.10 Mn |
| Dec 31, 2024 | 12.10 Mn |
| Sep 30, 2024 | -8.31 Mn |
| Sep 30, 2024 | -8.31 Mn |
| Jun 30, 2024 | 7.14 Mn |
| Jun 30, 2024 | 7.14 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 14.22 Mn |
| Dec 31, 2023 | 14.22 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Sep 30, 2023 | -1.00 Mn |